Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.50    0.00 (0.00%)
Bid:
109.00
Ask:
112.00
Spread: 3.00 (2.752%)
Market Cap: £66.48m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Positive Trading Update

6 Oct 2008 07:00

RNS Number : 1138F
Intercede Group PLC
06 October 2008
 



6 OCTOBER 2008

INTERCEDE GROUP plc

("Intercede" or "the Company")

Positive Trading Update

Intercede, a leading producer of Identity and Credential Management Systems (IDCMS) software, today announces excellent progress in the six months ended 30 September 2008.

Sales for the first half of the current financial year are more than 25% higher than for the comparable period last year. The Directors are also pleased to report that the Company has generated a profit at both pre and post tax level during the period. 

The improved results are attributable to the Company continuing to execute its strategyas stated in the 2008 Annual Report, of:

Adding to our list of major project wins

Refocusing our channel strategy to improve margins

Expanding our market to generate revenues from both the identity and credential management sectors

Increasing our professional service revenues

The growth in sales is especially encouraging, because the equivalent period last year included a one-off upfront licence order of £0.5 million from Thales, whereas this period's sales performance only includes 'business as usual' revenue items. Taking this into account, underlying sales have increased by 90% within a 12 month cycle.

We also announced last week a subcontract with Lockheed Martin worth an initial US$1 million, with an advance payment of US$500,000. This advance payment has been received, but only $46,000 has been recognised within first half sales.

Costs and cash collections have also been kept under control throughout the period, as evidenced by a half year cash balance of £1,839,000, compared to £1,153,000 at 31 March 2008. This means that the Company generated £686,000 of cash during the period,

Richard ParrisIntercede's Chairman and Chief Executive, said:

"I stated in the 2008 Annual Report that, with a number of exciting identity projects coming to market, Intercede was very well placed to continue its growth and that our business is as recession proof as it is possible to be in these challenging timesThis has proven to be the case, judging from the period's step change in trading performance. Our order book also suggests that, subject to any further macro-economic uncertainty, we remain on track to continue our planned growth trajectory."

Further details will be provided when Intercede announces its Interim Results for the six months ended 30 September 2008, which is expected to take place in December 2008.

About Intercede 

Intercede is the producer of the MyID™ Identity and Credential Management System (IDCMS). Intercede's MyID is renowned worldwide as the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

For more information visit http://www.intercede.com

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Pelham Public Relations

Tel. +44 (0)20 7743 6679

Archie Berens

Robert Koh

KBC Peel Hunt

Tel. + 44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKPKKFBDDBKK
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.